BioCentury
ARTICLE | Company News

Lightlake Therapeutics deal

November 3, 2014 8:00 AM UTC

Lightlake received $1 million from an undisclosed investor in exchange for interests in two of the company's products. Lightlake received $500,000 in exchange for a 0.98% interest in its opioid overdo...